))
The strategic negotiations behind the Allergan-Actavis merger amidst Valeant's hostile takeover bid.
Manage episode 429559830 series 3489545
Contenu fourni par Yadvinder Singh Rana. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Yadvinder Singh Rana ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In this episode, we'll explore the 66 billion $ merger negotiations between Allergan and Actavis, and the hostile takeover attempt by Valeant.
Joining me again is my special co-host, Alex, an advanced Artificial Intelligence known as ChatGPT.
Alex brings a unique perspective to our analysis, harnessing the power of AI to deepen our conversation.
If you enjoyed this episode, please leave a review and check out our website: neglob.com
I welcome any suggestions, questions, or comments at yrana@neglob.com
--------------------------------------------------------------------------------------------------
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.
8 episodes
Partager
